Showing 1 - 2 results of 2 for search 'Theo Leitner', query time: 0.01s Refine Results
  1. 1
    AI-based body composition analysis of CT data has the potential to predict disease course in patients with multiple myeloma

    AI-based body composition analysis of CT data has the potential to predict disease course in patients with multiple myeloma by Franz Wegner, Malte Maria Sieren, Hanna Grasshoff, Lennart Berkel, Christoph Rowold, Marcel Philipp Röttgerding, Soleiman Khalil, Sam Mogadas, Felix Nensa, René Hosch, Gabriela Riemekasten, Anna Franziska Hamm, Nikolas von Bubnoff, Jörg Barkhausen, Roman Kloeckner, Cyrus Khandanpour, Theo Leitner

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)

    Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnose... by Theo Leitner, Evgenii Shumilov, Christina Schwitlick, Raphael Koch, Franziska Hamm, Marion Högner, Florian Bassermann, Katja Weisel, Hermann Einsele, Martin Kortüm, Leo Rasche, Martin Görner, Kai Wegehenkel, Stefan Knop, Jan Krönke, Axel Nogai, Inke R. König, Maren Vens, Kay Horn, Nikolas von Bubnoff, Cyrus Khandanpour

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: